Last edition
News about "Unitaid"
Dr. Reddy's, Hetero to Produce Affordable Generic Lenacapavir For HIV Prevention by 2027
Indian pharmaceutical companies Dr. Reddy’s Laboratories and Hetero Labs (Hetero) have signed landmark agreements to manufacture generic versions of lenacapavir, a revolutionary long-acting HIV prevention drug, which will be available at roughly USD 40 per patient per year in low- and middle-income countries (LMICs) starting in 2027.
Unitaid | 29/09/2025 | By Dineshwori | 208
Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries under voluntary licence from ViiV Healthcare
Unitaid | 17/08/2023 | By Sudeep Soparkar | 592
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy